Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:162-168, doi:10.1016/j.jacc.2003.08.033
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalby, M.
Right arrow Articles by Thomas, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalby, M.
Right arrow Articles by Thomas, D.

Eptifibatide provides additional platelet inhibition in Non–ST-Elevation myocardial infarction patients already treated with aspirin and clopidogrel

Results of the platelet activity extinction in Non–Q-Wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study

Miles Dalby, MD*, Gilles Montalescot, MD, PhD*,*, Claire Bal dit Sollier, MD{dagger}, Eric Vicaut, MD, PhD{ddagger}, Thierry Soulat, MD{dagger}, Jean-Philippe Collet, MD, PhD*, Rémi Choussat, MD*, Vanessa Gallois, MSc*, Gérard Drobinski, MD, PhD*, Ludovic Drouet, MD{dagger} and Daniel Thomas, MD*

* Institut de Cardiologie, Pitié-Salpétrière University Hospital, Paris, France
{dagger} Department of Haematology, Hospital Lariboisiere, Paris, France
{ddagger} Unite de Recherche Clinique, Hospital Lariboisiere, Paris, France



View larger version (37K):

[in a new window]
 
Figure 1 Charts of conformationally active glycoprotein IIb/IIIa receptor expression (PAC-1) and anti-fibrinogen (Fg) before clopidogrel administration (T1), >2 h after clopidogrel (T2), and during eptifibatide infusion (T3). Receptor expression and Fg binding are expressed on the y axis as the mean number of sites expressed per platelet. ADP = adenosine diphosphate.

 


View larger version (48K):

[in a new window]
 
Figure 2 Charts of total glycoprotein IIb/IIIa receptor expression (P2) and P-selectin expression before clopidogrel administration (T1), >2 h after clopidogrel (T2), and during eptifibatide infusion (T3). Receptor expression and fibrinogen binding are expressed on the y axis as the mean number of sites expressed per platelet. "ns" is indicated in parenthesis for p values <0.05 but >0.0036 and therefore are not significant after Bonferonni correction. ADP = adenosine diphosphate.

 


View larger version (35K):

[in a new window]
 
Figure 3 Charts of platelet microparticle count as a function of blood volume (MPV) (top panel) and platelet count (MPP) (bottom panel) on the y axis before clopidogrel administration (T1), >2 h after clopidogrel (T2), and during eptifibatide infusion (T3).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement